We are live on ! Find out more
CSII

Cardiovascular Systems, Inc.

Delisted

CSII was delisted on the 27th of April, 2023.

174 hedge funds and large institutions have $836M invested in Cardiovascular Systems, Inc. in 2022 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 65 increasing their positions, 57 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 24

20% more capital invested

Capital invested by funds: $695M → $836M (+$141M)

14% more repeat investments, than reductions

Existing positions increased: 65 | Existing positions reduced: 57

4% more funds holding

Funds holding: 167174 (+7)

Holders
174
Holders Change
+7
Holders Change %
+4.19%
% of All Funds
2.74%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
32
Increased
65
Reduced
57
Closed
24
Calls
$1.75M
Puts
Net Calls
+$1.75M
Net Calls Change
+$1.28M

CSII Hedge Fund Activity: Q1 2022 in Review

174 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in Cardiovascular Systems, Inc. (CSII) for Q1 2022, worth a combined $836M — up 20% from $695M a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new CSII positions and 24 closed out — a net gain of 8 holders — while 65 added to existing stakes and 57 trimmed.

The largest buyer was Nuveen, adding an estimated $8.04M. The largest seller was Invesco, cutting an estimated $6.13M.

  • 174 institutional investors held Cardiovascular Systems, Inc. (CSII) as of Q1 2022, up from 167 in Q4 2021.
  • Funds reported $836M of Cardiovascular Systems, Inc. stock for Q1 2022, up 20% quarter-over-quarter.
  • 32 funds opened new Cardiovascular Systems, Inc. positions in Q1 2022 and 24 closed out, a net change of +8 holders.
  • The largest Cardiovascular Systems, Inc. buyer in Q1 2022 was Nuveen, an estimated $8.04M added.
  • The largest Cardiovascular Systems, Inc. seller in Q1 2022 was Invesco, an estimated $6.13M sold.

Based on aggregated 13F filings for Q1 2022.